BIOLASE, INC. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3a4758eb-402c-40d2-9a6d-d624539e0014/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $49.2M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-034812 |
| FY 2022 | $48.5M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-010364 |
| FY 2021 | $39.2M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004115 |
| FY 2020 | $22.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-017121 |
| FY 2019 | $37.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013794 |
| FY 2018 | $46.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006918 |
| FY 2017 | $46.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-006918 |
| FY 2016 | $51.8M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-006918 |
| FY 2015 | $48.5M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014571 |
| FY 2014 | $47.7M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001392 |
| FY 2013 | $56.4M | 2013-01-01 – 2013-12-31 | evidence 0001564590-14-000856 |
| FY 2012 | $57.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-110112 |
| FY 2011 | $48.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-112386 |
| FY 2010 | $26.2M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-112386 |
| FY 2009 | $43.3M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-112386 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).